Drugmakers have been targeted on national security grounds and could lose customers if Congress passes Biosecure Act
Biosecure Act would prohibit American companies receiving federal grant money from working with some Chinese groups
WuXi AppTec and WuXi Biologics under threat from proposed national security legislation
Wuxi Biologics is likely to miss its original sales target for the year by about $400mn
Slide for drugmaker WuXi Biologics wipes $10bn from market cap
